Global News

Exco InTouch successful completes HIPAA Privacy audit for NIST guidelines

Wednesday, July 20, 2016

Exco InTouch, a provider of patient engagement and data capture solutions for clinical research and healthcare providers, has announced that it has successfully undergone and completed an independent audit to assess compliance utilizing the National Institute of Standards and Technology (NIST) guidelines for Health Insurance Portability and Accountability Act (HIPAA), formally completing the independent auditing process for Privacy & Security.

[Read More]

Medidata launches new payment technology

Tuesday, July 19, 2016

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, has announced the launch of Medidata Payments. A new component of the industry-leading Medidata Clinical Cloud, Medidata Payments enables clinical trial sponsors and CROs to calculate reimbursements to investigative sites in real time and automatically disburse payments, eliminating a key operational pain point in the drug development process.

[Read More]

Boehringer Ingelheim, University of Dundee collaborate to develop new class of medicines

Tuesday, July 19, 2016

Boehringer Ingelheim and the University of Dundee will join forces in an exciting collaboration with the aim to develop a novel class of medicines that target disease causing proteins for degradation. The collaboration brings together the expertise of Dr Alessio Ciulli, one of the pioneers in the field of PROTACs and based in the School of Life Sciences at Dundee, with Boehringer Ingelheim’s expertise in drug discovery and clinical development of new therapeutic agents.

[Read More]

Dr. Andreas Rummelt joins supervisory board of Leukocare

Tuesday, July 19, 2016

Leukocare, a provider of stabilizing and protecting formulation technologies for biopharmaceuticals like biologics and vaccines, announced the election of Dr. Andreas Rummelt as new member of its supervisory board. Together with Dr. Jean-Paul Prieels, who held various executive positions at GlaxoSmithKline, former Sandoz CEO Dr. Rummelt is the second former executive from big pharma on the Leukocare board. 

[Read More]

The importance of the monitoring visit report

Monday, July 18, 2016

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

The monitoring visit report serves a spectrum of integral purposes specific to each monitoring visit type. It is the medium by which all findings identified at monitoring visits, and the status of findings from previous monitoring visits, are documented. It provides conceptual proof of training delivery for initiation visit conduct, and a logistical, clinical and developmental summary recommendation of the investigational site following the pre-study assessment. The closeout visit report signifies closure of investigational sites with submission and signature. The monitoring visit report is the full confirmation of monitoring processes at investigational sites.

[Read More]